株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

乳癌治療 - パイプライン製品の分析

Breast Cancer - Pipeline Review, 2015

発行 GlobalData 商品コード 344261
出版日 ページ情報 英文 352 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
乳癌治療 - パイプライン製品の分析 Breast Cancer - Pipeline Review, 2015
出版日: 2015年10月01日 ページ情報: 英文 352 Pages
概要

当レポートでは、乳癌治療におけるパイプライン製品について調査分析し、主要なパイプライン製品、主要企業、開発段階別のパイプライン製品、主な臨床試験データ、最近の動向について、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 乳癌治療の概要

第3章 開発中の製品

  • 乳癌治療 - パイプライン製品:開発段階別
  • 乳癌治療 - パイプライン製品:地域別
  • 乳癌治療 - パイプライン製品:規制経路別
  • 乳癌治療 - パイプライン製品:承認時期別 (予定)
  • 乳癌治療 - 進行中の臨床試験

第4章 乳癌治療:開発中のパイプライン製品 (企業別)

  • 乳癌治療企業 - パイプライン製品:開発段階別
  • 乳癌治療 - パイプライン製品:開発段階別

第5章 企業と製品の概要

  • A&G Pharmaceutical, Inc.
  • Abbott Diagnostics
  • Abcodia Ltd.
  • Abviva, Inc.
  • Accelerated Medical Diagnostics
  • Acobiom
  • Advanced Cell Diagnostics, Inc.
  • Affichem SA
  • AIT Austrian Institute of Technology GmbH
  • Almac Diagnostics Limited
  • Amarantus Bioscience Holdings, Inc.
  • AngioGenex, Inc.
  • Armune BioScience, Inc.
  • Arno Therapeutics, Inc.
  • AroCell AB
  • ArtemixRx
  • Ascendant Diagnostics, LLC
  • Assurance Biosciences, Inc.
  • Atossa Genetics, Inc.
  • Aurelium BioPharma Inc. (Inactive)
  • Autoimmune Technologies, LLC
  • Ayanda Biosystems S.A.
  • Becton, Dickinson and Company
  • Bio Gene Ltd.
  • BioAffinity Technologies, Inc.
  • Biocrates Life Sciences AG
  • Biodesix Inc.
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMark Technologies Inc.
  • BioMarker Strategies, LLC
  • bioMerieux S.A.
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • bioTheranostics, Inc.
  • Boston College
  • Candiag LLC.
  • Caprion Inc.
  • Cellanyx Diagnostics, Inc.
  • CellXplore, Inc.
  • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco
  • Cepheid
  • Ceres Nanosciences, Inc.
  • Cernostics Inc.
  • China Sky One Medical, Inc.
  • Chronix Biomedical, Inc.
  • Clarient, Inc.
  • Cleveland Diagnostics Inc.
  • Clovis Oncology, Inc.
  • CompanDX Ltd. など

第6章 乳癌治療:最近の動向

第7章 付録

図表

目次
Product Code: GDME0080EPD

GlobalData's Medical Devices sector report, "Breast Cancer - Pipeline Review, 2015" provides an overview of Breast Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Breast Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Breast Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Breast Cancer diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Breast Cancer diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Breast Cancer Overview

3. Products under Development

  • 3.1. Breast Cancer - Pipeline Products by Stage of Development
  • 3.2. Breast Cancer - Pipeline Products by Territory
  • 3.3. Breast Cancer - Pipeline Products by Regulatory Path
  • 3.4. Breast Cancer - Pipeline Products by Estimated Approval Date
  • 3.5. Breast Cancer - Ongoing Clinical Trials

4. Breast Cancer - Pipeline Products under Development by Companies

  • 4.1. Breast Cancer Companies - Pipeline Products by Stage of Development
  • 4.2. Breast Cancer - Pipeline Products by Stage of Development

5. Breast Cancer Companies and Product Overview

  • 5.1. A&G Pharmaceutical, Inc. Company Overview
  • 5.2. Abbott Diagnostics Company Overview
  • 5.3. Abcodia Ltd. Company Overview
  • 5.4. Abviva, Inc. Company Overview
  • 5.5. Accelerated Medical Diagnostics Company Overview
  • 5.6. Acobiom Company Overview
  • 5.7. Advanced Cell Diagnostics, Inc. Company Overview
  • 5.8. Affichem SA Company Overview
  • 5.9. AIT Austrian Institute of Technology GmbH Company Overview
  • 5.10. Almac Diagnostics Limited Company Overview
  • 5.11. Amarantus Bioscience Holdings, Inc. Company Overview
  • 5.12. AngioGenex, Inc. Company Overview
  • 5.13. Armune BioScience, Inc. Company Overview
  • 5.14. Arno Therapeutics, Inc. Company Overview
  • 5.15. AroCell AB Company Overview
  • 5.16. ArtemixRx Company Overview
  • 5.17. Ascendant Diagnostics, LLC Company Overview
  • 5.18. Assurance Biosciences, Inc. Company Overview
  • 5.19. Atossa Genetics, Inc. Company Overview
  • 5.20. Aurelium BioPharma Inc. (Inactive) Company Overview
  • 5.21. Autoimmune Technologies, LLC Company Overview
  • 5.22. Ayanda Biosystems S.A. Company Overview
  • 5.23. Becton, Dickinson and Company Company Overview
  • 5.24. Bio Gene Ltd. Company Overview
  • 5.25. BioAffinity Technologies, Inc. Company Overview
  • 5.26. Biocrates Life Sciences AG Company Overview
  • 5.27. Biodesix Inc. Company Overview
  • 5.28. BioMarCare Technologies Ltd. Company Overview
  • 5.29. BioMark Diagnostics Inc. Company Overview
  • 5.30. BioMark Technologies Inc. Company Overview
  • 5.31. BioMarker Strategies, LLC Company Overview
  • 5.32. bioMerieux S.A. Company Overview
  • 5.33. Biosceptre (Aust) Pty Ltd Company Overview
  • 5.34. BioSystems International Company Overview
  • 5.35. bioTheranostics, Inc. Company Overview
  • 5.36. Boston College Company Overview
  • 5.37. Candiag LLC. Company Overview
  • 5.38. Caprion Inc. Company Overview
  • 5.39. Cellanyx Diagnostics, Inc. Company Overview
  • 5.40. CellXplore, Inc. Company Overview
  • 5.41. Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Company Overview
  • 5.42. Cepheid Company Overview
  • 5.43. Ceres Nanosciences, Inc. Company Overview
  • 5.44. Cernostics Inc. Company Overview
  • 5.45. China Sky One Medical, Inc. Company Overview
  • 5.46. Chronix Biomedical, Inc. Company Overview
  • 5.47. Clarient, Inc. Company Overview
  • 5.48. Cleveland Diagnostics Inc. Company Overview
  • 5.49. Clovis Oncology, Inc. Company Overview
  • 5.50. CompanDX Ltd. Company Overview
  • 5.51. Courtagen Life Sciences, Inc. Company Overview
  • 5.52. CS-Keys, Inc. Company Overview
  • 5.53. Da An Gene Co., Ltd. Company Overview
  • 5.54. Dana-Farber Cancer Institute, Inc. Company Overview
  • 5.55. Dartmouth College Company Overview
  • 5.56. diaDexus, Inc. Company Overview
  • 5.57. Diaxonhit S.A. Company Overview
  • 5.58. Dublin City University Company Overview
  • 5.59. Eventus Diagnostics, Inc. Company Overview
  • 5.60. Exiqon A/S Company Overview
  • 5.61. Exosomics Siena SpA Company Overview
  • 5.62. Fermiscan Holdings Limited Company Overview
  • 5.63. Fina Biotech Company Overview
  • 5.64. Fluxion Biosciences, Inc. Company Overview
  • 5.65. Fournira Optime Diagnostics Company Overview
  • 5.66. GeneAssess, Inc. Company Overview
  • 5.67. GeneFluidics Inc. Company Overview
  • 5.68. GeneNews Limited Company Overview
  • 5.69. GenomicTree, Inc. Company Overview
  • 5.70. George Washington University Company Overview
  • 5.71. German Cancer Research Center Company Overview
  • 5.72. Ghent University Company Overview
  • 5.73. GILUPI Nanomedizin Company Overview
  • 5.74. GlycoZym Company Overview
  • 5.75. H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview
  • 5.76. Hai Kang Life Corporation Limited Company Overview
  • 5.77. Health Discovery Corporation Company Overview
  • 5.78. Hebrew University of Jerusalem Company Overview
  • 5.79. Heragen, Inc. Company Overview
  • 5.80. HistoRx, Inc. (Inactive) Company Overview
  • 5.81. HTG Molecular Diagnostics, Inc. Company Overview
  • 5.82. Ikonisys, Inc. Company Overview
  • 5.83. IncellDx, Inc. Company Overview
  • 5.84. Innovative Health Diagnostics Company Overview
  • 5.85. Insight Genetics, Inc. Company Overview
  • 5.86. Institut National de la Sante et de la Recherche Medicale Company Overview
  • 5.87. IRIS International, Inc. Company Overview
  • 5.88. IV Diagnostics, Inc. Company Overview
  • 5.89. Iverson Genetic Diagnostics, Inc. Company Overview
  • 5.90. Jonakee Cancer Research, Inc. Company Overview
  • 5.91. Kalgene Pharmaceuticals Inc. Company Overview
  • 5.92. KIYATEC Inc. Company Overview
  • 5.93. Leica Biosystems GmbH Company Overview
  • 5.94. Louisville Bioscience, Inc. Company Overview
  • 5.95. MabCure Inc. Company Overview
  • 5.96. Matritech, Inc. (Inactive) Company Overview
  • 5.97. Matrix-Bio, Inc. Company Overview
  • 5.98. MDNA Life Sciences, Inc. Company Overview
  • 5.99. MDxHealth SA Company Overview
  • 5.100. MEDITE Cancer Diagnostics, Inc. Company Overview
  • 5.101. MedMira Inc. Company Overview
  • 5.102. Metabolomic Technologies Inc. Company Overview
  • 5.103. MetaStat, Inc. Company Overview
  • 5.104. Milagen, Inc. Company Overview
  • 5.105. MiRXES Pte Ltd Company Overview
  • 5.106. National University of Ireland, Galway Company Overview
  • 5.107. Neogenix Oncology, Inc. Company Overview
  • 5.108. NeoMatrix, LLC (Inactive) Company Overview
  • 5.109. Novel Bio-spectrum Technologies, Inc. Company Overview
  • 5.110. Nuclea Biotechnologies Inc. Company Overview
  • 5.111. Nuvera Biosciences, Inc. Company Overview
  • 5.112. Olink AB Company Overview
  • 5.113. Onconome, Inc. Company Overview
  • 5.114. OncoStem Diagnostics Pvt. Ltd Company Overview
  • 5.115. OncoVista Innovative Therapies, Inc. Company Overview
  • 5.116. On-Q-ity, Inc. (Inactive) Company Overview
  • 5.117. Orion Genomics LLC Company Overview
  • 5.118. OTraces Inc. Company Overview
  • 5.119. Panacea Pharmaceuticals, Inc. Company Overview
  • 5.120. PeriRx LLC Company Overview
  • 5.121. Power3 Medical Products, Inc. Company Overview
  • 5.122. PreMD Inc. Company Overview
  • 5.123. Proplex Technologies, Llc Company Overview
  • 5.124. Protagen AG Company Overview
  • 5.125. Proteome Sciences Plc Company Overview
  • 5.126. Proteomika Company Overview
  • 5.127. Provista Diagnostics Inc. Company Overview
  • 5.128. Qiagen N.V. Company Overview
  • 5.129. Quest Diagnostics Incorporated Company Overview
  • 5.130. Rna Diagnostics Inc. Company Overview
  • 5.131. Roche Diagnostics International Ltd. Company Overview
  • 5.132. Rosetta Genomics, Ltd. Company Overview
  • 5.133. Savicell Diagnostic Ltd. Company Overview
  • 5.134. Selventa Company Overview
  • 5.135. Sengenics International Pte Ltd Company Overview
  • 5.136. Siamab Therapeutics, Inc. Company Overview
  • 5.137. Siemens Healthcare Diagnostics Inc. Company Overview
  • 5.138. Sividon Diagnostics GmbH Company Overview
  • 5.139. Soricimed Biopharma Inc. Company Overview
  • 5.140. Target Discovery, Inc. Company Overview
  • 5.141. Taxor Diagnostics, LLC Company Overview
  • 5.142. The Johns Hopkins University Company Overview
  • 5.143. Todos Medical Company Overview
  • 5.144. Trinity College Dublin Company Overview
  • 5.145. University of Alberta Company Overview
  • 5.146. University of California, San Diego Company Overview
  • 5.147. University of Chicago Company Overview
  • 5.148. University of Colorado Company Overview
  • 5.149. University of Maryland, Baltimore Company Overview
  • 5.150. University of Nebraska Company Overview
  • 5.151. University of Oxford Company Overview
  • 5.152. University of South Florida Company Overview
  • 5.153. University of Wisconsin Madison Company Overview
  • 5.154. US Biomarkers, Inc. Company Overview
  • 5.155. Vermillion, Inc. Company Overview
  • 5.156. Viomics Inc. Company Overview
  • 5.157. Vitatex Inc. Company Overview
  • 5.158. Vitruvian Biomedical, Inc. Company Overview
  • 5.159. VolitionRX Ltd. Company Overview
  • 5.160. XEPTAGEN SpA Company Overview
  • 5.161. Xiamen Zeesan Biotech Co.,Ltd Company Overview
  • 5.162. Zetiq Technologies Ltd. Company Overview

6. Breast Cancer- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Breast Cancer - Pipeline Products by Stage of Development
  • Table 2: Breast Cancer - Pipeline Products by Territory
  • Table 3: Breast Cancer - Pipeline Products by Regulatory Path
  • Table 4: Breast Cancer - Pipeline Products by Estimated Approval Date
  • Table 5: Breast Cancer - Ongoing Clinical Trials
  • Table 6: Breast Cancer Companies - Pipeline Products by Stage of Development
  • Table 7: Breast Cancer - Pipeline Products by Stage of Development
  • Table 8: A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Onco 88 - Breast Cancer - Product Status
  • Table 10: Onco 88 - Breast Cancer - Product Description
  • Table 11: OncoStain 88 - Breast Cancer - Product Status
  • Table 12: OncoStain 88 - Breast Cancer - Product Description
  • Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: CKS1B Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 15: CKS1B Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 16: cMET Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 17: cMET Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 18: FGFR1 Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 19: FGFR1 Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 20: FGFR2 Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 21: FGFR2 Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 22: HER2 Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 23: HER2 Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 24: IGF1R Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 25: IGF1R Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 26: PIK3CA Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 27: PIK3CA Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 28: PTEN Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 29: PTEN Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 30: TOP2A Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 31: TOP2A Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 32: ZNF217 Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 33: ZNF217 Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 34: Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Molecular Biomarker - Breast Cancer - Product Status
  • Table 36: Molecular Biomarker - Breast Cancer - Product Description
  • Table 37: Abviva, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Diagnostic Assay - Mammastatin - Product Status
  • Table 39: Diagnostic Assay - Mammastatin - Product Description
  • Table 40: Accelerated Medical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Companion Diagnostic Test - Oxaliplatin - Product Status
  • Table 42: Companion Diagnostic Test - Oxaliplatin - Product Description
  • Table 43: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
  • Table 45: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
  • Table 46: Advanced Cell Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: RNAscope HER2 - Product Status
  • Table 48: RNAscope HER2 - Product Description
  • Table 49: Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: AF300 Based Enzymatic Immunoassay Kit - Product Status
  • Table 51: AF300 Based Enzymatic Immunoassay Kit - Product Description
  • Table 52: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Diagnostic Assay - Cancer - Product Status
  • Table 54: Diagnostic Assay - Cancer - Product Description
  • Table 55: Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Diagnostic Test - Breast Cancer - Product Status
  • Table 57: Diagnostic Test - Breast Cancer - Product Description
  • Table 58: Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: NuroPro - Breast Cancer - Product Status
  • Table 60: NuroPro - Breast Cancer - Product Description
  • Table 61: AngioGenex, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Status
  • Table 63: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Description
  • Table 64: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
  • Table 65: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
  • Table 66: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
  • Table 67: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
  • Table 68: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Status
  • Table 69: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Description
  • Table 70: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
  • Table 71: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
  • Table 72: Armune BioScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Diagnostic Test - Breast Cancer - Product Status
  • Table 74: Diagnostic Test - Breast Cancer - Product Description
  • Table 75: Arno Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Activated Estrogen Receptor Biomarker Assay - Product Status
  • Table 77: Activated Estrogen Receptor Biomarker Assay - Product Description
  • Table 78: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Status
  • Table 79: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Description
  • Table 80: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: TK 210 Assay - Breast Cancer - Product Status
  • Table 82: TK 210 Assay - Breast Cancer - Product Description
  • Table 83: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: ArtemixRx Prognostic Test - Breast Cancer - Product Status
  • Table 85: ArtemixRx Prognostic Test - Breast Cancer - Product Description
  • Table 86: Ascendant Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: MelodyDX - Product Status
  • Table 88: MelodyDX - Product Description
  • Table 89: Assurance Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Salivary-Based Assay - Breast Cancer - Product Status
  • Table 91: Salivary-Based Assay - Breast Cancer - Product Description
  • Table 92: Atossa Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: ArgusCYTE CTC Test - Product Status
  • Table 94: ArgusCYTE CTC Test - Product Description
  • Table 95: Companion Diagnostic Test - Breast Cancer - Product Status
  • Table 96: Companion Diagnostic Test - Breast Cancer - Product Description
  • Table 97: Next Generation MASCT System - Product Status
  • Table 98: Next Generation MASCT System - Product Description
  • Table 99: NextCYTE Lymph Node Predictor Test - Product Status
  • Table 100: NextCYTE Lymph Node Predictor Test - Product Description
  • Table 101: Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: Breast Cancer Screening Test - Product Status
  • Table 103: Breast Cancer Screening Test - Product Description
  • Table 104: MMD ELISA Test - Breast Cancer - Product Status
  • Table 105: MMD ELISA Test - Breast Cancer - Product Description
  • Table 106: Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: Diagnostic Assay - Breast Cancer - Product Status
  • Table 108: Diagnostic Assay - Breast Cancer - Product Description
  • Table 109: Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Diagnostic Test - Breast Cancer - Product Status
  • Table 111: Diagnostic Test - Breast Cancer - Product Description
  • Table 112: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Diagnostic Test - Breast Cancer - Product Status
  • Table 114: Diagnostic Test - Breast Cancer - Product Description
  • Table 115: Bio Gene Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Diagnostic Test - Breast Cancer - Product Status
  • Table 117: Diagnostic Test - Breast Cancer - Product Description
  • Table 118: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: CyPath Diagnostic Assay - Breast Cancer - Product Status
  • Table 120: CyPath Diagnostic Assay - Breast Cancer - Product Description
  • Table 121: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 122: Metabolomic Biomarker Assay - Breast Cancer - Product Status
  • Table 123: Metabolomic Biomarker Assay - Breast Cancer - Product Description
  • Table 124: Biodesix Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: VeriStrat - Breast Cancer - Product Status
  • Table 126: VeriStrat - Breast Cancer - Product Description
  • Table 127: BioMarCare Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Breast Cancer - Pipeline Products by Stage of Development
  • Figure 2: Breast Cancer - Pipeline Products by Territory
  • Figure 3: Breast Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Breast Cancer - Pipeline Products by Estimated Approval Date
  • Figure 5: Breast Cancer - Ongoing Clinical Trials
Back to Top